Fully human HER2/cluster of differentiation 3 bispecific antibody triggers potent and specific cytotoxicity of T lymphocytes against breast cancer.
about
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells.Recent advances of bispecific antibodies in solid tumors.Harnessing the immune system in the battle against breast cancer.A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity.
P2860
Fully human HER2/cluster of differentiation 3 bispecific antibody triggers potent and specific cytotoxicity of T lymphocytes against breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fully human HER2/cluster of di ...... hocytes against breast cancer.
@ast
Fully human HER2/cluster of di ...... hocytes against breast cancer.
@en
type
label
Fully human HER2/cluster of di ...... hocytes against breast cancer.
@ast
Fully human HER2/cluster of di ...... hocytes against breast cancer.
@en
prefLabel
Fully human HER2/cluster of di ...... hocytes against breast cancer.
@ast
Fully human HER2/cluster of di ...... hocytes against breast cancer.
@en
P2093
P2860
P356
P1476
Fully human HER2/cluster of di ...... hocytes against breast cancer.
@en
P2093
Hai-Rong Liu
Jiang-Man Wang
Jin-Liang Yang
Lan-Tu Gou
Shu-Xian Zhou
Xiao-An Li
Zhi-Hui Guo
P2860
P304
P356
10.3892/MMR.2015.3441
P577
2015-03-05T00:00:00Z